IL161674A0 - Methods and means for producing proteins with predetermined post-translational modifications - Google Patents
Methods and means for producing proteins with predetermined post-translational modificationsInfo
- Publication number
- IL161674A0 IL161674A0 IL16167402A IL16167402A IL161674A0 IL 161674 A0 IL161674 A0 IL 161674A0 IL 16167402 A IL16167402 A IL 16167402A IL 16167402 A IL16167402 A IL 16167402A IL 161674 A0 IL161674 A0 IL 161674A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- translational modifications
- predetermined post
- producing proteins
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2001/000792 WO2003050286A1 (en) | 2001-10-29 | 2001-10-29 | Methods and means for producing proteins with predetermined post-translational modifications |
PCT/NL2002/000257 WO2003089468A1 (en) | 2002-04-19 | 2002-04-19 | Methods and means for producing proteins with predetermined post-translational modifications |
PCT/NL2002/000686 WO2003038100A1 (en) | 2001-10-29 | 2002-10-29 | Methods and means for producing proteins with predetermined post-translational modifications |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161674A0 true IL161674A0 (en) | 2004-09-27 |
Family
ID=19760777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16167402A IL161674A0 (en) | 2001-10-29 | 2002-10-29 | Methods and means for producing proteins with predetermined post-translational modifications |
Country Status (7)
Country | Link |
---|---|
KR (3) | KR100692784B1 (en) |
CN (1) | CN101177700B (en) |
AU (1) | AU2002224199A1 (en) |
IL (1) | IL161674A0 (en) |
MX (1) | MXPA04003940A (en) |
WO (1) | WO2003050286A1 (en) |
ZA (1) | ZA200403209B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9244235B2 (en) | 2008-10-17 | 2016-01-26 | Foro Energy, Inc. | Systems and assemblies for transferring high power laser energy through a rotating junction |
TWI532495B (en) * | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | Pharmaceutical preparation |
CN102818896B (en) * | 2011-06-09 | 2014-12-17 | 北京华大蛋白质研发中心有限公司 | Detection method of nitration modification sites based on specific antibodies and antibody capable of specifically recognizing succinyl-CoA: 3-oxoacid CoA transferase (SCOT) nitration sites |
EP3382014A1 (en) * | 2017-03-29 | 2018-10-03 | CEVEC Pharmaceuticals GmbH | Recombinant glycoproteins with reduced antennary fucosylation |
EP4219537A1 (en) * | 2020-09-22 | 2023-08-02 | Jecho Laboratories, Inc. | Glycosylation-modified erythopoietin and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789247A (en) | 1994-04-01 | 1998-08-04 | Ballay; Annick | Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
JP3688718B2 (en) * | 1997-03-27 | 2005-08-31 | ザ・ユニバーシティー・オブ・ブリティッシュ・コランビア | Insect expression vector |
SI1533380T1 (en) * | 1999-04-15 | 2010-03-31 | Crucell Holland Bv | Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus |
-
2001
- 2001-10-29 WO PCT/NL2001/000792 patent/WO2003050286A1/en active Application Filing
- 2001-10-29 AU AU2002224199A patent/AU2002224199A1/en not_active Abandoned
-
2002
- 2002-10-29 IL IL16167402A patent/IL161674A0/en unknown
- 2002-10-29 KR KR1020047006311A patent/KR100692784B1/en not_active IP Right Cessation
- 2002-10-29 KR KR1020067008077A patent/KR100737639B1/en not_active IP Right Cessation
- 2002-10-29 MX MXPA04003940A patent/MXPA04003940A/en active IP Right Grant
- 2002-10-29 KR KR1020067008079A patent/KR100602772B1/en not_active IP Right Cessation
- 2002-10-29 CN CN2007101494988A patent/CN101177700B/en not_active Expired - Fee Related
-
2004
- 2004-04-28 ZA ZA200403209A patent/ZA200403209B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101177700B (en) | 2012-03-21 |
MXPA04003940A (en) | 2004-11-29 |
CN101177700A (en) | 2008-05-14 |
WO2003050286A1 (en) | 2003-06-19 |
KR100602772B1 (en) | 2006-07-20 |
AU2002224199A1 (en) | 2003-06-23 |
KR20060057648A (en) | 2006-05-26 |
ZA200403209B (en) | 2005-01-14 |
KR100692784B1 (en) | 2007-03-12 |
KR20050040824A (en) | 2005-05-03 |
KR100737639B1 (en) | 2007-07-09 |
KR20060057647A (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL149029A0 (en) | High mannose proteins and methods for producing the same | |
GB0208331D0 (en) | Proteins | |
GB0209884D0 (en) | Proteins | |
GB0130557D0 (en) | Proteins | |
IL156660A0 (en) | Methods for identifying and producing hla-a2 supermotif-restricted peptides | |
IL161674A0 (en) | Methods and means for producing proteins with predetermined post-translational modifications | |
EP1487874A4 (en) | Falp proteins | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
GB0212067D0 (en) | Proteins | |
HK1062924A1 (en) | Methods and means for producing proteins with predetermined post- translational modifications | |
AU2002307635A1 (en) | Methods and means for producing proteins with predetermined post-translational modifications | |
AU2003270055A8 (en) | Neurotransmission-associated proteins | |
GB0223860D0 (en) | Polypeptide methods and means | |
GB2370039B (en) | Producing protein arrays and fusion protein for use therein | |
GB0106782D0 (en) | Polypeptides, methods and means | |
AU2003300785A8 (en) | Carbohydrate-associated proteins | |
AU2002326909A8 (en) | Neurotransmission-associated proteins | |
AU2002329235A1 (en) | Method for producing microparticles loaded with proteins | |
AU2003236908A8 (en) | Proteins | |
AU2003295760A8 (en) | Organelle-associated proteins | |
GB0216757D0 (en) | Proteins | |
TWI318239B (en) | Methods for producing novel medaka and novel medaka | |
GB0130739D0 (en) | Proteins | |
GB0128596D0 (en) | Proteins | |
GB0108895D0 (en) | Proteins |